Stock Quote
Clinical Data Inc (CLDA.W) (NASD ADF)
sector: Healthcare .
industry: Medical Equipment, Supplies & Distribution ยท
View CLDA on other exchanges
$15.21
19 Nov 2009
-3.67%
$15.79
$15.11
500
$15.34
$15.11
$21.94
$6.38
1.70
167,674
CLDA.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Kirk, Randal | Chairman of the Board | -- |
| Fromkin, Andrew | President, Chief Executive Officer, Director | 2,457,250 |
| Ballantyne, C. Evan | Chief Financial Officer, Executive Vice President | 784,953 |
Profile
Clinical Data, Inc. is a biotechnology company with a focuses on the development of therapeutics. Its late stage compounds include vilazodone, a potential first-in-class drug candidate for the treatment of depression, and apadenoson, which is trademarked under the name Stedivaze a potential... Full Description
Company Address
Clinical Data Inc
One Gateway Center
Suite 702
Newton MA 02458
P: +1617.5279933
One Gateway Center
Suite 702
Newton MA 02458
P: +1617.5279933
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Amgen, Inc. | $56.25 | +0.87 |
| GlaxoSmithKline plc | £1,267.00 | -10.50 |
| Pfizer Inc. | $18.53 | +0.17 |
| CLDA.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.76 |
| P/S(TTM) | 30.11 | 0.51 |
| ROI(TTM) | -142.90 | 2.54 |
| ROE(TTM) | -227.76 | 4.01 |
| Consensus Recommendation | Buy |
|---|---|
| EPS Est. (Current Period) | -0.64 |
| EPS Est. (Current Year) | -2.81 |
| Total Revenue | $3.69M |
| Net Income | $-20.25M |
| EPS | $-0.88 |
